US Patent Issued to Bristol-Myers Squibb on Jan. 20 for "Stabilized fibronectin based scaffold molecules" (Massachusetts Inventor)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,529,165, issued on Jan. 20, was assigned to Bristol-Myers Squibb Co. (Princeton, N.J.).

"Stabilized fibronectin based scaffold molecules" was invented by Dasa Lipovsek (Pepperell, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are proteins comprising a fibronectin based scaffold (FBS) domain, e.g., 10Fn3 molecules, that bind specifically to a target, and wherein the FBS domain is linked at its C-terminus to a region consisting of PmXn, wherein P is proline, X is any amino acid and wherein n is 0 or an integer that is at least 1 and m is an integer that is at least 1, and wherein the PmXn moiety provides an enhanced property to the ...